Literature DB >> 19930982

Obstructive sleep apnea and heart failure.

Andrew D Calvin1, Felipe N Albuquerque, Taro Adachi, Virend K Somers.   

Abstract

Obstructive sleep apnea (OSA) exerts several effects that may be particularly deleterious in patients with heart failure (HF). OSA should be considered especially in HF patients who are obese or have the metabolic syndrome, systemic hypertension, or pulmonary hypertension. HF patients in whom OSA is suspected should undergo a full evaluation by a sleep specialist, including a polysomnogram, to diagnose OSA and differentiate this disease from central sleep apnea. Those found to have OSA should then receive continuous positive airway pressure and/or other interventions, and standard disease management strategies should be used to maximize compliance. Those who cannot tolerate continuous positive airway pressure may be candidates for mandibular advancement devices or surgical therapies including tracheostomy. Standard HF medications should be used to treat HF, and optimization of fluid balance may help minimize OSA severity. However, it is still unknown whether treatment of OSA in HF patients will reduce hospitalizations or mortality.

Entities:  

Year:  2009        PMID: 19930982     DOI: 10.1007/s11936-009-0047-z

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  59 in total

1.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.

Authors:  Apoor S Gami; Dave O Hodge; Regina M Herges; Eric J Olson; Jiri Nykodym; Tomas Kara; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

2.  Continuous positive airway pressure for central sleep apnea and heart failure.

Authors:  T Douglas Bradley; Alexander G Logan; R John Kimoff; Frédéric Sériès; Debra Morrison; Kathleen Ferguson; Israel Belenkie; Michael Pfeifer; John Fleetham; Patrick Hanly; Mark Smilovitch; George Tomlinson; John S Floras
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

3.  Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women.

Authors:  T Young; L Evans; L Finn; M Palta
Journal:  Sleep       Date:  1997-09       Impact factor: 5.849

4.  Influence of obstructive sleep apnea on mortality in patients with heart failure.

Authors:  Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

5.  Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations.

Authors:  S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

Review 6.  Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines.

Authors:  Charles W Atwood; Douglas McCrory; Joe G N Garcia; Steven H Abman; Gregory S Ahearn
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

Review 7.  Effects and side-effects of surgery for snoring and obstructive sleep apnea--a systematic review.

Authors:  Karl A Franklin; Heidi Anttila; Susanna Axelsson; Thorarinn Gislason; Paula Maasilta; Kurt I Myhre; Nina Rehnqvist
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

8.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

Review 9.  Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis.

Authors:  C McDaid; S Griffin; H Weatherly; K Durée; M van der Burgt; S van Hout; J Akers; R J O Davies; M Sculpher; M Westwood
Journal:  Health Technol Assess       Date:  2009-01       Impact factor: 4.014

10.  Elective tracheostomy is an alternative treatment in patients with severe obstructive sleep apnoea syndrome and CPAP failure.

Authors:  Nanna Browaldh; Agneta Markström; Danielle Friberg
Journal:  Acta Otolaryngol       Date:  2009-10       Impact factor: 1.494

View more
  2 in total

1.  Sleep apnea, heart failure, and sleep position.

Authors:  Ozcan Ozeke; Cagatay Ertan; Ahmet Duran Demir
Journal:  Sleep Breath       Date:  2011-11-09       Impact factor: 2.816

2.  Treatment of cardiomyopathy with PAP therapy in a patient with severe obstructive sleep apnea.

Authors:  Ritu G Grewal
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.